Member Exclusive

Notch signaling inhibitor shows promise for cancer treatment in Phase I trial

Trial results presented at the 28th EORTC-NCI-AACR Symposium (Munich, Germany) suggest a Notch signalling inhibitor is safe and effective for a range of cancers.

Go to the profile of RxNet
Dec 06, 2016

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.